Evidence map›Paper›PMID 35949846›Full record

ArticleWorld journal of clinical cases2022

Liver transplantation for late-onset ornithine transcarbamylase deficiency: A case report.

Xiao-Hui Fu, Yu-Hui Hu, Jian-Xiang Liao, Li Chen, Zhan-Qi Hu, Jia-Lun Wen, Shu-Li Chen

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. In-depth analysis ofFrontiers in pediatrics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiao-Hui FuDepartment of Inherited Metabolic Disorders, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.
Yu-Hui HuDepartment of Inherited Metabolic Disorders, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.
Jian-Xiang LiaoDepartment of Neurology, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.
Li ChenDepartment of Neurology, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.
Zhan-Qi HuDepartment of Neurology, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.
Jia-Lun WenDepartment of Neurology, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.
Shu-Li ChenDepartment of Inherited Metabolic Disorders, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China. 13008803656@163.com.
Shenzhen Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOrnithine transcarbamylase deficiency (OTCD) is an X-linked inherited disorder and characterized by marked elevation of blood ammonia. The goal of treatment is to minimize the neurological damage caused by hyperammonemia. OTCD can be cured by liver transplantation (LT). Post-transplant patients can discontinue anti- hyperammonemia agents and consume a regular diet without the risk of developing hyperammonemia. The neurological damage caused by hyperammonemia is almost irreversible. CASE SUMMARY: An 11.7-year-old boy presented with headache, vomiting, and altered consciousness. The patient was diagnosed with late-onset OTCD. After nitrogen scavenging treatment and a protein-free diet, ammonia levels were reduced to normal on the third day of admission. Nevertheless, the patient remained in a moderate coma. After discussion, LT was performed. Following LT, the patient's blood ammonia and biochemical indicators stabilized in the normal range, he regained consciousness, and his nervous system function significantly recovered. Two months after LT, blood amino acids and urine organic acids were normal, and brain magnetic resonance imaging showed a decrease in subcortical lesions.

conclusionLT can significantly improve partial neurological impairment caused by late-onset OTCD hyperammonemic encephalopathy, and LT can be actively considered when early drug therapy is ineffective.

Indexed as

Case reportHyperammonemic encephalopathyLiver transplantationOrnithine transcarbamylase deficiencyUrea cycle disorder

Identifiers

PMID35949846
PMCPMC9254178
OpenAlexW4282958495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.